Vitrian is the first fully integrated company dedicated exclusively to providing end-to-end solutions for biomanufacturing and cGMP facilities. Its core activities include facility real estate investment and development, improving the capitalization process, and building capacity through civic engagement and workforce development. The firm is actively engaged in training and capacity building for the entry-level biomanufacturing workforce across its primary markets. Current engagements span modalities across advanced therapeutics, aseptic fill/finish, synthetic biology, and radiopharma, with active projects in 6+ U.S. markets. Financially, Vitrian closed a $50 million initial investment (with the ability to scale to $65 million) into AmplifyBio’s Manufacturing Enablement Center in New Albany, Ohio as a first step of a larger commitment to support biomanufacturing in Central Ohio. Vitrian says it plans further collaboration with AmplifyBio and to leverage local infrastructure and workforce development to expand capacity in the region.

Total raised

$50M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2024